Your browser doesn't support javascript.
loading
Geometric parameters that affect the behavior of logic-gated CAR T cells.
Partin, Alexander C; Bruno, Richele; Shafaattalab, Sanam; Vander Mause, Erica; Winters, Aaron; Daris, Mark; Gahrs, Casey; Jette, Claudia A; DiAndreth, Breanna; Sandberg, Mark L; Hamburger, Agnes E; Kamb, Alexander; Riley, Timothy P.
Afiliação
  • Partin AC; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Bruno R; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Shafaattalab S; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Vander Mause E; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Winters A; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Daris M; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Gahrs C; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Jette CA; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • DiAndreth B; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Sandberg ML; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Hamburger AE; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Kamb A; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
  • Riley TP; A2 Biotherapeutics, Inc., Agoura Hills, CA, United States.
Front Immunol ; 15: 1304765, 2024.
Article em En | MEDLINE | ID: mdl-38343543
ABSTRACT
Clinical applications of CAR-T cells are limited by the scarcity of tumor-specific targets and are often afflicted with the same on-target/off-tumor toxicities that plague other cancer treatments. A new promising strategy to enforce tumor selectivity is the use of logic-gated, two-receptor systems. One well-described application is termed Tmod™, which originally utilized a blocking inhibitory receptor directed towards HLA-I target antigens to create a protective NOT gate. Here we show that the function of Tmod blockers targeting non-HLA-I antigens is dependent on the height of the blocker antigen and is generally compatible with small, membrane-proximal targets. We compensate for this apparent limitation by incorporating modular hinge units to artificially extend or retract the ligand-binding domains relative to the effector cell surface, thereby modulating Tmod activator and blocker function. By accounting for structural differences between activator and blocker targets, we developed a set of simple geometric parameters for Tmod receptor design that enables targeting of blocker antigens beyond HLA-I, thereby broadening the applications of logic-gated cell therapies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos